Syndecan-1 was reported to increase up to 100-fold in trauma patients [21], 65-fold in patients undergoing major vascular surgery with global and regional ischemia [22], 8-fold in septic patients [12], and 3- to 4-fold after cardiac surgery [23, 24] or after resuscitated cardiac arrest [25]. The gene discussed is SDC1; the disease is cardiac arrest.